Ironwood Pharmaceuticals, Inc.  

(Public, NASDAQ:IRWD)   Watch this stock  
Find more results for IRWD
14.17
+0.36 (2.61%)
Nov 26 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 13.52 - 14.20
52 week 9.01 - 15.95
Open 13.79
Vol / Avg. 0.00/1.02M
Mkt cap 1.98B
P/E     -
Div/yield     -
EPS -1.55
Shares 123.61M
Beta 1.52
Inst. own 110%
Jan 19, 2015
Q4 2014 Ironwood Pharmaceuticals Inc Earnings Release (Estimated) - 12:00AM EST - Add to calendar
Nov 11, 2014
Ironwood Pharmaceuticals Inc at Credit Suisse Healthcare Conference
Nov 4, 2014
Q3 2014 Ironwood Pharmaceuticals Inc Earnings Call - Webcast
Nov 4, 2014
Q3 2014 Ironwood Pharmaceuticals Inc Earnings Release
Sep 10, 2014
Ironwood Pharmaceuticals Inc at Morgan Stanley Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -248.19% -1192.31%
Operating margin -217.16% -1101.36%
EBITD margin - -1050.10%
Return on average assets -46.96% -107.22%
Return on average equity -134.74% -299.34%
Employees 534 -
CDP Score - -

Address

301 BINNEY STREET
CAMBRIDGE, MA 02142-1030
United States - Map
+1-617-6217722 (Phone)
+1-617-4940480 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Ironwood Pharmaceuticals, Inc. is a pharmaceutical company, which discovers, develops and intends to commercialize differentiated medicines. The Company is engaged in the area of guanylate cyclase type-C (GC-C), agonists and in the science and treatment of gastrointestinal diseases. Its two GC-C agonists are linaclotide and IW-9179.

Officers and directors

Bryan E. Roberts Ph.D. Independent Chairman of the Board
Age: 47
Bio & Compensation  - Reuters
Peter M. Hecht Ph.D. Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Michael J. Higgins Chief Operating Officer
Age: 51
Bio & Compensation  - Reuters
Thomas Graney Chief Financial Officer, Senior Vice President - Finance, Corporate Strategy
Age: 49
Bio & Compensation  - Reuters
Mark G. Currie Ph.D. Senior Vice President, Chief Scientific Officer, President - Research and Development
Age: 59
Bio & Compensation  - Reuters
Thomas A. McCourt Senior Vice President - Marketing and Sales, Chief Commercial Officer
Age: 56
Bio & Compensation  - Reuters
Gina Consylman Chief Accounting Officer, Vice President, Corporate Controller
Age: 42
Bio & Compensation  - Reuters
Douglas E. Williams Ph.D. Director
Age: 56
Bio & Compensation  - Reuters
George H. Conrades Independent Director
Age: 75
Bio & Compensation  - Reuters
Joseph C. Cook Jr. Independent Director
Age: 72
Bio & Compensation  - Reuters